Anti-IL6R Therapy (Tocilizumab) Improves Long-Term Patient & Graft Survival in Patients with Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy.

被引：0
|
作者：
Choi, J. [1 ]
Vo, A. [1 ]
Haas, M. [1 ]
Puliyanda, D. [1 ]
Louie, S. [1 ]
Peng, A. [1 ]
Kahwaji, J. [1 ]
Villicana, R. [1 ]
Kim, I. [1 ]
Mirocha, J. [1 ]
Jordan, S. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Comprehens Transplantat Ctr, Los Angeles, CA 90048 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
416
引用
收藏
页码：350 / 350
页数：1
相关论文
共 47 条
  • [1] Safety and Efficacy of Tocilizumab (anti-IL6R, TCZ) Therapy in the Treatment of Antibody-Mediated Rejection (ABMR) in Pediatric Renal Transplant Patients
    Steggerda, Justin
    Puliyanda, Dechu
    Todo, Tsuyoshi
    Haas, Mark
    Zhang, Xioahai
    Choi, Jua
    Pizzo, Helen
    Jordan, Stanley
    Kim, Irene
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 52 - 52
  • [2] Saftey & Long Term Outcomes of Tocilizumab (Anti-IL6R, TCZ) Therapy in Treatment of Chronic Antibody Mediated Rejection (CABMR) & Transplant Glomerulopathy (TG) in Highly-HLA Sensitized (HS) Patients (PTs)
    Choi, J.
    Aubert, O.
    Vo, A.
    Loupy, A.
    Haas, M.
    Louie, S.
    Kang, A.
    Peng, A.
    Najjar, R.
    Huang, E.
    Toyota, M.
    Zhang, X.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 308 - 308
  • [3] Long Term Safety and Efficacy of Tocilizumab (anti-il6r, Tcz) Therapy in the Treatment of Refractory Chronic Antibody Mediated Rejection (cabmr) in 25 Pediatric Renal Transplant Recipients
    Pearl, M.
    Weng, P.
    Dokras, A.
    Pizzo, H.
    Garrison, J.
    Butler, C.
    Zhang, J. Q.
    Lim, K.
    Reed, E.
    Kim, I.
    Haas, M.
    Zhang, X.
    Ettenger, R.
    Jordan, S.
    Puliyanda, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 323 - 323
  • [4] Safety and Efficacy of Tocilizumab (anti-IL6R, TCZ) Therapy in the Treatment of Chronic Antibody Mediated Rejection (cABMR) in Pediatric Renal Transplant Recipients.
    Puliyanda, D.
    Kim, I.
    Choi, J.
    Haas, M.
    Zhang, X.
    Vo, A.
    Pizzo, H.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 267 - 268
  • [5] Extended Experience Using Tocilizumab (Anti-IL6R, TCZ) for the Treatment of Chronic Antibody Mediated Rejection (CABMR).
    Choi, J.
    Aubert, O.
    Louie, S.
    Ammerman, N.
    Vo, A.
    Peng, A.
    Huang, E.
    Najjar, R.
    Puliyanda, D.
    Sethi, S.
    Haas, M.
    Lim, K.
    Loupy, A.
    Jordan, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 326 - 327
  • [6] SAFETY AND EFFICACY OF TOCILIZUMAB (ANTI-IL6R, TCZ) THERAPY IN THE TREATMENT OF CHRONIC ANTIBODY MEDIATED REJECTION (CABMR) IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS.
    Puliyanda, D.
    Kim, I.
    Choi, J.
    Haas, M.
    Zhang, X.
    Vo, A.
    Pizzo, H.
    Jordan, S.
    PEDIATRIC TRANSPLANTATION, 2017, 21 : 2 - 2
  • [7] Impact of Tocilizumab (Anti-IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients With Chronic Antibody-mediated Rejection
    Shin, Bong-Ha
    Everly, Matthew J.
    Zhang, Hao
    Choi, J.
    Vo, Ashley
    Zhang, Xiaohai
    Huang, Edmund
    Jordan, Stanley C.
    Toyoda, Mieko
    TRANSPLANTATION, 2020, 104 (04) : 856 - 863
  • [8] Early Antibody-Mediated Rejection Portends Worse Long-Term Renal Graft and Patient Survival
    Orandi, B.
    Chow, E.
    Van Arendonk, K.
    Montgomery, J.
    Gupta, N.
    Montgomery, R.
    Segev, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 324 - 324
  • [9] Late and Chronic Antibody-Mediated Rejection: Main Barrier to Long Term Graft Survival
    Sun, Qiquan
    Yang, Yang
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2013,
  • [10] Long-term graft survival in patients with chronic antibody-mediated rejection with persistent peritubular capillaritis treated with intravenous immunoglobulin and rituximab
    Mulley, William R.
    Huang, Louis L.
    Chandran, Sharmila Ramessur
    Longano, Anthony
    Amos, Liv A. R.
    Polkinghorne, Kevan R.
    Nikolic-Paterson, David J.
    Kanellis, John
    CLINICAL TRANSPLANTATION, 2017, 31 (09)
12345